Lv2
148 积分 2023-04-08 加入
PCSK9 inhibition with orally administered NNC0385-0434 in hypercholesterolaemia: a randomised, double-blind, placebo-controlled and active-controlled phase 2 trial
3个月前
已完结
Efficacy and Safety of Oral PCSK9 Inhibitor Enlicitide in Adults With Heterozygous Familial Hypercholesterolemia
3个月前
已完结
A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection
4个月前
已完结
Coadministered Cagrilintide and Semaglutide in Adults with Overweight or Obesity
4个月前
已完结
Cagrilintide–Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
4个月前
已完结
皖公网安备34019202002308
